Dabrafenib and Trametinib in Treating Patients With BRAF Mutated Ameloblastoma
Clinical trial NCT02367859 · COMPLETED
Trial details
- NCT number
- NCT02367859
- Sponsor
- Stanford University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-17
- Primary completion
- 2018-11-05
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.